Nicotine Patch Trial in Syrian Primary Care Settings
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The study is a two-arm, parallel group, randomized, placebo-controlled, double blind trial,
conducted at four primary health care centers in Aleppo, Syria, to test the efficacy of
transdermal nicotine patch therapy vs. placebo patch therapy, when delivered with behavioral
counseling, on smoking cessation rates.